Together, these results indicate that B7H3.BC CAR-T cells with subdued tonic signaling are functionally enhanced and capable of overcoming key barriers of persistence, exhaustion, and tumor infiltration that limit the efficacy of other CAR-T cell designs in DIPG. Here, CD276 is linked to neoplasm.